Novel HIV vaccine shows lasting potential in non-human primates

Written by Lucy Chard (Future Science Group)

HIV vaccine tested in RM

A research collective from across the USA including from Emory University (Atlanta, GA, USA) and Stanford University (CA, USA), among others, have developed a new vaccine for HIV, which is better at preventing infection as well as lasting for a year after inoculation. The new vaccine marked improvement is down to exploiting alliance between neutralizing antibodies and cellular immunity. “Most efforts to develop an HIV vaccine focus on activating the immune system to make antibodies that can inactivate the virus, so called neutralizing antibodies,” explained Eric Hunter, Professor at Emory, and a researcher at the Emory Vaccine Center (EVC; GA,...

To view the full article, please register now for access

It's completely free